| |
|
|
|
|
|
|
|
 Inside the Issue
|
Generic Times Feature
 - Generic—and Biogeneric—Medicines Set to Play Important Role in Health Care
Kathleen Jaeger, GPhA President and Chief Executive Officer - Generic, Biogeneric Meds Save Patients Greenbacks
Kathleen Jaeger, GPhA President and Chief Executive Officer - Branded Generics: Misunderstood, but Lucrative
- Rx Response Steps Up When Disaster Strikes
Kathleen Jaeger, GPhA President and Chief Executive Officer - "Carve Outs" Harm Patients, Increase Cost
Kathleen Jaeger, GPhA President and Chief Executive Officer - E-prescribing: The "Write" Way to Go
Kathleen Jaeger, GPhA President and Chief Executive Officer - Patent Expirations Could Mean Biologics Competition
Ed Lamb - Generic Industry Year in Review
Kathleen Jaeger, GPhA President and Chief Executive Officer - Watch for Blockbuster Generics over Next Year
Ed Lamb - Ensuring Adequate Competition
a Concern with Generics Mergers
Ed Lamb - Unintended Outcomes May Prompt PDMA Rule Changes
Ed Lamb - Generics Are Boon to Those on Medicaid, Bane to Pharmacists
Ed Lamb - Leading Generics Companies Combine Quality with Savings
Wendy K. Bodine, Assistant Editor - Compulsory Licensing: A Necessary Evil?
Ed Lamb - A Message from Kathleen Jaeger: Congress Needs to Act Now to Approve Biogenerics
|
|
|
|
|
|
|
|
| |
|
Intellisphere, LLC l 666 Plainsboro Road, Building 300, Plainsboro, NJ 08536 l P 609-716-7777 l F 609-716-4747
|
 |
Copyright ©MDNG 2006-2009
Intellisphere, LLC
All Rights Reserved
|
|
|
|
|
|
